Related Experiment Video
Updated: Jul 4, 2026
08:12
Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
Mitral valve repair for infective endocarditis.
Tadashi Omoto1, Masahiro Ohno, Masaomi Fukuzumi
1Department of Cardiovascular Surgery, Showa University Hospital, Hatanodai 1-5-8, Shinagawa-ku, Tokyo 142-8555, Japan. tomoto@med.showa-u.ac.jp
General Thoracic and Cardiovascular Surgery
|June 20, 2008
Summary
Mitral valve (MV) repair is a feasible option for patients with infective endocarditis (IE), preserving better left ventricular (LV) function and structure postoperatively compared to MV replacement.
Area of Science:
- Cardiovascular Surgery
- Infective Endocarditis
- Valvular Heart Disease
Background:
- Infective endocarditis (IE) frequently affects the mitral valve (MV), leading to mitral regurgitation (MR).
- Surgical intervention is often necessary for IE-related MR, with repair versus replacement being a critical decision.
Purpose of the Study:
- To assess the feasibility of mitral valve (MV) repair in patients with active or healed infective endocarditis (IE) causing mitral regurgitation (MR).
- To evaluate the impact of MV repair on left ventricular (LV) function and structure postoperatively.
Main Methods:
- Retrospective analysis of 19 patients undergoing MV operations for IE between December 2004 and September 2007.
- MV repair was attempted in 15 patients with acute IE (67% success) and 4 with healed IE (100% success).
Main Results:
- No perioperative or late deaths occurred; one patient required redo MV repair.
- Postoperative MR was trivial or mild in all repaired valves.
- MV repair resulted in significant reductions in LV end-diastolic and end-systolic dimensions, and improved LV function (ejection fraction, fraction shortening) compared to MV replacement.
Conclusions:
- Mitral valve (MV) repair is a viable and safe surgical option for patients with active or healed infective endocarditis (IE).
- MV repair offers superior preservation of left ventricular (LV) function and structure compared to mitral valve replacement in this patient cohort.
Related Concept Videos
01:18Endocarditis III: Medical Management
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:25Endocarditis I: Introduction
Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
01:25Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
01:22Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
01:22Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...